Verified Nov 2026
Other
·

Milan, Lombardy
·
Since 1926
Recordati is a Milan-based pharmaceutical group founded in 1926 that develops and manufactures specialty medicines, primary care therapies, and treatments for rare diseases across approximately 150 countries. The company, which has 1,000–5,000 employees and generated $1–5 billion in revenue, operates two main segments: Specialty and Primary Care (covering cardiovascular, urology, and dermatology conditions) and Rare Diseases (targeting endocrinology and oncology). In November 2026, a consortium led by CVC Capital Partners and GBL secured over 90% of the company's shares, clearing the path to take Recordati private.
Recordati at a glance
Revenue
$1-5B
Est. band
Employees
1,000-5,000
Founded
1926
Headquarters
Milan, Lombardy
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
Overview
Recordati is a Milan-based pharmaceutical group founded in 1926 that develops and manufactures specialty medicines, primary care therapies, and treatments for rare diseases across approximately 150 countries. The company, which has 1,000–5,000 employees and generated $1–5 billion in revenue, operates two main segments: Specialty and Primary Care (covering cardiovascular, urology, and dermatology conditions) and Rare Diseases (targeting endocrinology and oncology). In November 2026, a consortium led by CVC Capital Partners and GBL secured over 90% of the company's shares, clearing the path to take Recordati private.
At a glance
Attribute | Detail |
|---|---|
Founded | 1926 |
Headquarters | Milan, Lombardy |
Employees | 1,000-5,000 |
Revenue | $1-5B (estimated) |
What Recordati makes
The company develops and manufactures proprietary pharmaceutical brands, licensed products, and active pharmaceutical ingredients, with specific offerings including ZANIDIP for hypertension and specialized orphan drug treatments.
Latest developments
2026-11-09 — CVC, GBL secure over 90% of Recordati, clear path to delisting | live (euronext.com)
2026-11-09 — Italy: CVC-led consortium secures record €7.58bn financing for Recordati take-private - Investors in Healthcare (investorsinhealthcare.com)
2026-11-06 — White & Case advises on record-breaking €7.58 billion (equivalent) financing for take-private acquisition of Recordati by consortium led by CVC Capital Partners | White & Case LLP (whitecase.com)
2026-11-05 — Latham Advises CVC GBL Consortium and Respighi on Groundbreaking Financing (lw.com)
2026-05-27 — 27 May 2026 - Extract of agreements (Investment and Partnership Agreement; Rossini Undertaking to Tender and LP Co Investor Agreements) published in “Il Corriere della Sera” and “Il Sole 24 Ore” on 27 May 2026 (in italian only) - Recordati (recordati.com)
2026-02-17 — RECORDATI REPORTS STRONG PRELIMINARY FULL YEAR 2025 (globenewswire.com)
Facilities
Recordati is headquartered in Milan, Lombardy. Public sources also reference these locations:
Cork, Ireland — abb.com
Company details
Recordati operates production and distribution facilities across multiple regions, including a manufacturing site in Cork, Ireland, and serves healthcare providers and patients in approximately 150 countries. Recordati was founded in 1926, has an estimated 1,000-5,000 employees, and is headquartered in Milan, Lombardy.
Frequently asked questions
What does Recordati do?
Recordati is a Milan-based pharmaceutical group founded in 1926 that develops and manufactures specialty medicines, primary care therapies, and treatments for rare diseases across approximately 150 countries. The company, which has 1,000–5,000 employees and generated $1–5 billion in revenue, operates two main segments: Specialty and Primary Care (covering cardiovascular, urology, and dermatology conditions) and Rare Diseases (targeting endocrinology and oncology). In November 2026, a consortium led by CVC Capital Partners and GBL secured over 90% of the company's shares, clearing the path to take Recordati private.
Where is Recordati headquartered?
Recordati is headquartered in Milan, Lombardy.
When was Recordati founded?
Recordati was founded in 1926.
How big is Recordati?
Recordati has an estimated 1,000-5,000 employees, with revenue in the $1-5B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
